OmniAb, Inc.

NASDAQ:OABI

Biotechnology

Healthcare
$5.03 +7.88%

+$0.16 today

Market cap
$733.68M
Beta
1.15
P/E (TTM)
-5.2
EPS (TTM)
-$0.42
52W Low $1.30High $2.79

Volume 1.75M

Average 0.67M

Income Statement

Follow revenue through to earnings.

Revenue

$18.67M

FY 2025 · Annual

-29.3% YoY

Operating Income

-$71.52M

FY 2025 · Annual

Net Income

-$64.78M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue34.75M59.08M34.16M26.39M18.67M
Cost of Revenue000022.06M
Gross Profit34.75M59.08M34.16M26.39M(3.39M)
Gross Margin100.0%100.0%100.0%100.0%-18.2%
Research & Development39.23M48.36M56.53M55.11M47.75M
Selling, General & Admin16.95M24.9M33.31M30.74M29.22M
Operating Expenses70.36M85.73M103.58M100.89M68.13M
Depreciation & Amortization16.25M18.25M19.5M23.58M21.75M
EBITDA(18.09M)(7.81M)(44.87M)(47.83M)(44.54M)
EBITDA Margin-52.1%-13.2%-131.3%-181.2%-238.6%
Operating Income(35.61M)(26.65M)(69.42M)(74.5M)(71.52M)
Operating Margin-102.5%-45.1%-203.2%-282.3%-383.1%
Interest Income0587K5.06M3.11M2.66M
Interest Expense7K0000
Other Income / Expenses1.26M587K5.06M3.09M5.22M
Income Before Tax(34.35M)(26.06M)(64.36M)(71.41M)(66.29M)
Pre-Tax Margin-98.9%-44.1%-188.4%-270.6%-355.2%
Income Tax Expense(7.31M)(3.73M)(13.74M)(9.38M)(1.52M)
Net Income(27.04M)(22.33M)(50.62M)(62.03M)(64.78M)
Net Margin-77.8%-37.8%-148.2%-235.1%-347.0%
EPS (Basic)(0.24)(0.26)(0.51)(0.61)(0.57)
EPS (Diluted)(0.24)(0.26)(0.51)(0.61)(0.57)
Weighted Avg Shares114.82M85.32M99.68M102.37M113.64M
Weighted Avg Shares (Diluted)114.82M85.32M99.68M102.37M113.64M

OABI Earnings Waterfall · TTM

NASDAQ:OABI · Revenue to Net Income

Key Ratios

EPS$-0.46
Gross Margin12.6%
Net Margin-342.0%
P/E Ratio-4.1
P/S Ratio42.9

Analysis

$28.9M of revenue converted into -$54.3M of net income for the selected period. Gross margin is 12.6% and net margin is -342.0%, showing how much revenue survives after costs and taxes. EPS is $-0.46, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 2, 2026
8-KCurrent reportOct 30, 2026
10-QQuarterly reportOct 30, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
10-QQuarterly reportAug 6, 2026

How much revenue does OABI generate?

OmniAb, Inc. (OABI) reported $18.67M of revenue in fiscal 2025.

Is OABI profitable?

OmniAb, Inc. (OABI) reported -$64.78M of net income, with a net margin of -347.0%.